Structural overexpression of CCND1 in MCL tumor cells is a driving cytogenetic abnormality in MCL tumorogenesis.[1] However, given that CCND1 is a weak oncogene, the aggressive disease pattern always results from secondary cytogenetic events. This evidence concerns the gene CCND1 and neoplasm.